258
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Development and Validation of an Oxidative Phosphorylation-Related Gene Signature in Lung Adenocarcinoma

ORCID Icon, , , , , & ORCID Icon show all
Pages 1333-1348 | Received 27 May 2020, Accepted 22 Jul 2020, Published online: 13 Aug 2020

References

  • Bray F , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
  • Siegel RL , MillerKD , JemalA. Cancer statistics, 2020. CA Cancer J. Clin.70(1), 7–30 (2020).
  • Shi J , HuaX , ZhuBet al. Somatic genomics and clinical features of lung adenocarcinoma: a retrospective study. PLoS Med.13(12), e1002162 (2016).
  • Liang Y , WakeleeHA. Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC). Transl. Lung Cancer Res.2(5), 403–410 (2013).
  • Blandin Knight S , CrosbiePA , BalataH , ChudziakJ , HussellT , DiveC. Progress and prospects of early detection in lung cancer. Open Biol.7(9), 170070 (2017).
  • Carter BW , LichtenbergerJP , BenvenisteMKet al. Revisions to the TNM staging of lung cancer: rationale, significance, and clinical application. Radiographics38(2), 374–391 (2018).
  • Sica V , Bravo-SanPedro JM , StollG , KroemerG. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. Int. J. Cancer146(1), 10–17 (2020).
  • Ashton TM , McKennaWG , Kunz-SchughartLA , HigginsGS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res.24(11), 2482–2490 (2018).
  • Kuntz EM , BaqueroP , MichieAMet al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat. Med.23(10), 1234–1240 (2017).
  • Nayak AP , KapurA , BarroilhetL , PatankarMS. Oxidative phosphorylation: a target for novel therapeutic strategies against ovarian cancer. Cancers10(9), 337 (2018).
  • Rao S , MondragónL , PranjicBet al. AIF-regulated oxidative phosphorylation supports lung cancer development. Cell Res.29(7), 579–591 (2019).
  • Seijo LM , PeledN , AjonaDet al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J. Thorac. Oncol.14(3), 343–357 (2019).
  • Kwa M , MakrisA , EstevaFJ. Clinical utility of gene-expression signatures in early stage breast cancer. Nat. Rev. Clin. Oncol.14(10), 595–610 (2017).
  • Zhu X , TianX , YuCet al. A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Mol. Cancer15(1), 60 (2016).
  • Tomczak K , CzerwińskaP , WiznerowiczM. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol.19(1A), A68 (2015).
  • Colaprico A , SilvaTC , OlsenCet al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res.44(8), e71 (2016).
  • Edgar R , DomrachevM , LashAE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res.30(1), 207–210 (2002).
  • Davis S , MeltzerPS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics23(14), 1846–1847 (2007).
  • Brown GR , HemV , KatzKSet al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res.43(D1), D36–D42 (2015).
  • Robinson JL , KocabaşP , WangHet al. An atlas of human metabolism. Sci. Signal.13(624), eaaz1482 (2020).
  • Robinson MD , McCarthyDJ , SmythGK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics26(1), 139–140 (2010).
  • Benjamini Y , HochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B Methodol.57(1), 289–300 (1995).
  • Wickham H . ggplot2: Elegant Graphics for Data Analysis (2nd Edition).Springer, Cham, Switzerland (2016).
  • Kolde R . Pheatmap: pretty heatmaps. R package version61, 617 (2012).
  • Yu G , WangL-G , HanY , HeQ-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS16(5), 284–287 (2012).
  • Walter W , Sánchez-CaboF , RicoteM. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics31(17), 2912–2914 (2015).
  • Kuhn M . Building predictive models in R using the caret package. J. Stat. Softw.28(5), 1–26 (2008).
  • Gordon M , LumleyT. forestplot: advanced forest plot using ‘grid’graphics. R package version1(2), 70 (2017).
  • Friedman J , HastieT , TibshiraniR. glmnet: lasso and elastic-net regularized generalized linear models. R package version1(4), (2009). http://CRAN.R-project.org/package=glmnet
  • Heagerty P , SahaP. SurvivalROC: time-dependent ROC curve estimation from censored survival data. Biometrics56(2), 337–344 (2000).
  • Harrell FE Jr . rms: regression modeling strategies. R package version5(2), (2016). http://CRAN.R-project.org/package=rms
  • Mayakonda A , LinD-C , AssenovY , PlassC , KoefflerHP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res.28(11), 1747–1756 (2018).
  • Robin X , TurckN , HainardAet al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics12(1), 77 (2011).
  • Sun W , HuS , ZuY , DengY. KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer. Mol. Carcinog.58(11), 1933–1945 (2019).
  • Chen Y-J , GuoY-N , ShiKet al. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Respir. Res.20(1), 48 (2019).
  • Zhang J-X , SongW , ChenZ-Het al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol.14(13), 1295–1306 (2013).
  • Liu N , ChenN-Y , CuiR-Xet al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol.13(6), 633–641 (2012).
  • Zhang L , ZhangZ , YuZ. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. J. Transl. Med.17(1), 423 (2019).
  • Gu Y , LiP , PengFet al. Autophagy-related prognostic signature for breast cancer. Mol. Carcinog.55(3), 292–299 (2016).
  • Shen S , WangG , ZhangRet al. Development and validation of an immune gene-set based prognostic signature in ovarian cancer. EBioMedicine40, 318–326 (2019).
  • Xu X-H , BaoY , WangXet al. Hypoxic-stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non-small cell lung cancer. FASEB J. doi:10.1096/fj.201700715 (2018) ( Epub ahead of print).
  • Yang S , LiuY , LiM-Yet al. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Mol. Cancer16(1), 124 (2017).
  • Nagano H , HashimotoN , NakayamaAet al. p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells. Proc. Natl Acad. Sci. U S A115(33), 8370–8375 (2018).
  • Warfel NA , El-DeiryWS. HIF-1 signaling in drug resistance to chemotherapy. Curr. Med. Chem.21(26), 3021–3028 (2014).
  • Von Morze C , MerrittME. Cancer in the crosshairs: targeting cancer metabolism with hyperpolarized carbon-13 MRI technology. NMR Biomed.32(10), e3937 (2019).
  • Fu H , ZhuY , WangYet al. Identification and validation of stromal immunotype predict survival and benefit from adjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin. Cancer Res.24(13), 3069–3078 (2018).
  • Sohn I , KimJ , JungS-H , ParkC. Gradient lasso for Cox proportional hazards model. Bioinformatics25(14), 1775–1781 (2009).
  • Yan S , WangY , ChenM , LiG , FanJ. Deregulated SLC2A1 promotes tumor cell proliferation and metastasis in gastric cancer. Int. J. Mol. Sci.16(7), 16144–16157 (2015).
  • Jin L , ChunJ , PanCet al. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene36(27), 3797–3806 (2017).
  • Pathria G , ScottDA , FengYet al. Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J.37(20), e99735 (2018).
  • Amaral MD , QuaresmaMC , PankonienI. What role does CFTR play in development, differentiation, regeneration and cancer?Int. J. Mol. Sci.21(9), 3133 (2020).
  • Li Y , SunZ , WuYet al. Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer70(1), 14–21 (2010).
  • Kim S-K , KimK , RyuJ-Wet al. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer. Int. J. Oncol.54(1), 65–76 (2019).
  • Qin Q , XuY , HeT , QinC , XuJ. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res.22(1), 90–106 (2012).
  • Pan J , FangS , TianHet al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Mol. Cancer19(1), 9 (2020).
  • Shi J , LiJ , YangSet al. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway. J. Cell. Physiol.235(3), 2891–2900 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.